Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025;31(22):1800-1815.
doi: 10.2174/0113816128342642250111055339.

Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency

Affiliations

Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency

Wusheng Zhong et al. Curr Pharm Des. 2025.

Abstract

Aim: Quercetin, a bioactive flavonoid extracted from traditional Chinese medicine, has antihepatocellular carcinoma effects. Farnesoid X receptor (FXR), a nuclear receptor highly expressed in the liver, plays important roles in maintaining hepatic glucose homeostasis, anti-inflammation, liver regeneration, and anti-cancer properties. Whether quercetin regulates the glycolysis/glycolysis pathway through FXR signaling remains unknown.

Methods: KEGG Enrichment, GO Enrichment, Protein-Protein Interaction (PPI) Network, Molecular Docking, and RNA-Seq Analysis (Swiss Target Prediction, GeneCard databases, Kaplan-Meier Plotter, etc). Cell activity, cell proliferation, and cell cycles were separately analyzed by CCK-8 assay, clone formation assay, and flow cytometry. QRT-PCR determined the mRNA levels of related genes in response to quercetin. HPLCMS/ MSHPLC-MS/MS determined the metabolite profiles. FXR deficiency Hep3B cells were used for discriminating the quercetin's effects with or without FXR.

Results: Quercetin-related genes were significantly correlated with FXR in hepatocarcinogenesis, especially in glycolysis. The top 30 related genes between FXR, quercetin, and glycolysis were enriched and chosen to further study. Furthermore, the strongest binding energy determined by the molecular docking model of between quercetin and FXR was -6.55 kcal/mol. Quercetin inhibited cell proliferation by the accumulation of Hep3B cells in the S-phase. The differential expressed genes (C-MYC, PCNA, CYCLIN-D1, and P21) associated with glycolysis were observed. Furthermore, quercetin also inhibited the expression of HK2, GAPDH, and LDHA. Meanwhile, the levels of glycolysis/gluconeogenesis-related metabolites were regulated by quercetin.

Conclusion: Quercetin makes an essential anti-HCC effect by crippling the glycolysis/gluconeogenesis process via FXR signaling.

Keywords: Farnesoid X receptor; HCC; HPLC-MS/MS; Quercetin; glycolysis; hepatocarcinogenesis..

PubMed Disclaimer

Similar articles

References

    1. Rumgay H.; Arnold M.; Ferlay J.; Lesi O.; Cabasag C.J.; Vignat J.; Laversanne M.; McGlynn K.A.; Soerjomataram I.; Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 2022,77(6),1598-1606 - DOI - PubMed
    1. Llovet J.M.; Kelley R.K.; Villanueva A.; Singal A.G.; Pikarsky E.; Roayaie S.; Lencioni R.; Koike K.; Rossi Z.J.; Finn R.S.; Hepatocellular carcinoma. Nat Rev Dis Primers 2021,7(1),6 - DOI - PubMed
    1. Singal A.G.; Kanwal F.; Llovet J.M.; Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy. Nat Rev Clin Oncol 2023,20(12),864-884 - DOI - PubMed
    1. Gonzalez F.J.; Jiang C.; Patterson A.D.; An intestinal microbiota–farnesoid x receptor axis modulates metabolic disease. Gastroenterology 2016,151(5),845-859 - DOI - PubMed
    1. Tschuck J.; Theilacker L.; Rothenaigner I.; Weiß S.A.I.; Akdogan B.; Lam V.T.; Müller C.; Graf R.; Brandner S.; Pütz C.; Rieder T.; Kopplin S.P.; Vincendeau M.; Zischka H.; Schorpp K.; Hadian K.; Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis. Nat Commun 2023,14(1),6908 - DOI - PubMed

MeSH terms

Substances